A theme involving the issuance of the 10th Series of Stock Acquisition Rights to Growth Capital as the allottee to raise funds for research and development expenses, including clinical trials for TMS-007, and working capital. This also includes ongoing fundraising through the exercise of the stock acquisition rights.